In this episode, Cameron Kiani interviews Ken Gillman, MD, on using Monoamine Oxidase Inhibitors in clinical practice.

Dr. Gillman is a Queensland-based psychiatrist considered to be one of the world's leading experts on MAOIs. He recently published a statement “Revitalizing monoamine oxidase inhibitors: a call for action” in the journal CNS Spectrums.

Cameron Kiani is a fourth year medical student at Icahn School of Medicine at Mount Sinai with an interest in treatment-resistant mood disorders.

“Revitalizing monoamine oxidase inhibitors: a call for action”